CNND yields 4.91% · JNJ yields 2.13%● Live data
📍 CNND pulled ahead of the other in Year 1
Combined, CNND + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CNND + JNJ for your $10,000?
Canandaigua National Corporation operates as the bank holding company for The Canandaigua National Bank & Trust Company and Canandaigua National Trust Company of Florida that provides various banking and financial services. The company offers checking, savings, and certificate of deposit accounts, as well as debit and credit cards. It also provides commercial and industrial loans, such as term loans and lines of credit comprising loans to businesses for working capital, including inventory and receivables; business expansion covering the acquisition of real estate, expansion, and improvements; and equipment purchases. In addition, the company offers commercial real estate loans; one-to-four-family residential real estate loans for the construction, purchase, or refinancing of a mortgage; home equity lines of credit and second mortgage loans; indirect loans; and other consumer loans, including automobile, recreational vehicle, boat, aircraft, home improvement, and personal loans. Further, it provides investment management, financial planning, trust and estate, retirement, and insurance services. Additionally, the company offers cash management services; and online, mobile, and text banking, as well as bill pay, custodial, payroll, workplace banking, and ATM services. It serves individuals, corporations, and municipalities in Ontario County and Monroe County of New York State. The company was founded in 1887 and is based in Canandaigua, New York.
Full CNND Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.